Skip to main content
. 2017 Sep 6;8(59):99707–99721. doi: 10.18632/oncotarget.20686

Table 4a. Progression Free Results for Non-Muscle Invasive Bladder Cancer.

Univariate Analyses1 Multivariate Analyses1
n Median2 HR3 LCL UCL p4 n Median2 HR3 LCL UCL p4
Age (years)
 ≤ 65 183 41.7 1.00 181 36.8 1.00
 > 65 317 14.6 1.84 1.29 2.63 .0008 317 15.9 1.67 1.16 2.40 .006
Gender
 Female 95 21.2 1.00 95 18.2 1.00
 Male 405 22.1 0.98 0.66 1.46 .92 403 22.6 0.88 0.59 1.32 .54
Tumor Grade
 Low 219 50.5 1.00 219 36.2 1.00
 High 279 11.4 2.47 1.74 3.52 <.0001 279 14.5 1.74 1.04 2.92 .03
Tumor Stage
 Ta or Tis 253 44.6 1.00 252 27.8 1.00
 T1 247 11.0 2.34 1.68 3.27 <.0001 246 16.7 1.42 0.87 2.33 .16
Lymph Nodes
 N0 or NX 487 23.5 1.00 486 22.8 1.00
 N1 13 1.3 5.98 3.22 11.11 <.0001 12 2.8 4.25 2.20 8.21 <.0001
ANG
 0-2 408 25.6 1.00 408 24.3 1.00
 3-4 29 22.9 1.08 0.55 2.13 .83 28 26.2 0.97 0.47 2.00 .92
MMP-2
 0-2 175 26.1 1.00 173 25.5 1.00
 3-4 281 21.6 1.06 0.75 1.49 .75 281 20.4 1.09 0.77 1.55 .63
 5-6 2 17.8 1.12 0.56 2.22 2 16.2 1.19 0.59 2.39
p53
 0-2 284 29.8 1.00 284 23.6 1.00
 3-4 173 18.3 1.33 1.01 1.75 .04 173 21.5 1.08 0.81 1.44 .60
 5-6 24 11.3 1.77 1.03 3.06 24 19.5 1.17 0.65 2.08
Rb
 0-2 97 23.6 1.00 96 22.4 1.00
 3-4 347 27.4 0.93 0.62 1.40 .74 347 28.0 0.89 0.58 1.35 .58
 5-6 3 31.7 0.87 0.38 1.97 3 35.1 0.79 0.34 1.83
PAI-1
 0-2 192 20.8 1.00 191 17.3 1.00
 3-4 277 22.2 0.89 0.65 1.23 .49 277 26.0 0.72 0.51 1.02 .06
 5-6 8 23.6 0.80 0.42 1.50 8 39.2 0.52 0.26 1.03

1Univariate analyses are unadjusted. Multivariate analyses are adjusted for age, sex, tumor grade, tumor stage, and lymph nodes.

2Median is the median years progression free as estimated from a parametric model.

3HR is the hazard ratio from a semiparametric (Cox proportional hazards) model. The 95% confidence limits (LCL and UCL) are shown.

4The expression p-values are for trend.